BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26122907)

  • 1. Commentary on: Hegedüs A. and Kozel B. (2014). Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review. International Journal of Mental Health Nursing, doi: 10.1111/inm.12089.
    Gray R; Bressington D; von Bormann S; Schulz M; Brown E; Anderson K; Jones M
    Int J Ment Health Nurs; 2015 Aug; 24(4):370-2. PubMed ID: 26122907
    [No Abstract]   [Full Text] [Related]  

  • 2. In response to the Commentary to our systematic review 'Does adherence therapy improve medication adherence among patients with schizophrenia?'.
    Hegedüs A; Kozel B
    Int J Ment Health Nurs; 2015 Aug; 24(4):373-4. PubMed ID: 26245521
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
    Bressington D; Mui J; Gray R
    Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review.
    Hegedüs A; Kozel B
    Int J Ment Health Nurs; 2014 Dec; 23(6):490-7. PubMed ID: 25279684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
    Samalin L; de Chazeron I; Blanc O; Brunel L; Fond G; Llorca PM
    Schizophr Res; 2016 Dec; 178(1-3):1-5. PubMed ID: 27637362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving treatment adherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Affecting Medication Adherence Among Adults with Schizophrenia: A Literature Review.
    Tham XC; Xie H; Chng CM; Seah XY; Lopez V; Klainin-Yobas P
    Arch Psychiatr Nurs; 2016 Dec; 30(6):797-809. PubMed ID: 27888977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How to improve compliance in the patients with schizophrenia?].
    Gourevitch R
    Encephale; 2006 Oct; 32(5 Pt 4):S929-30. PubMed ID: 17119511
    [No Abstract]   [Full Text] [Related]  

  • 9. Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs).
    Beebe LH; Smith K; Phillips C
    Arch Psychiatr Nurs; 2016 Jun; 30(3):400-5. PubMed ID: 27256948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novelty seeking and medication adherence in patients with schizophrenia.
    Aukst Margetić B; Jakovljević M; Ivanec D; Tošić G; Margetić B
    Psychiatry Res; 2011 Mar; 186(1):141-3. PubMed ID: 20630601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
    Chang YT; Tao SG; Lu CL
    Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
    Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
    Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Adherence in Hospitalized Patients Diagnosed With Schizophrenia: An Integrative One-on-One Intervention.
    Dahan S; Behrbalk P; Stolovy T; Greenberger C
    Arch Psychiatr Nurs; 2016 Dec; 30(6):660-665. PubMed ID: 27888956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
    Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication Adherence Decisions in Patients With Schizophrenia.
    Kikkert MJ; Dekker J
    Prim Care Companion CNS Disord; 2017 Dec; 19(6):. PubMed ID: 29216418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining Medication Adherence in the Treatment of Schizophrenia: How Current Approaches to Adherence Lead to Misinformation and Threaten Therapeutic Relationships.
    Weiden PJ
    Psychiatr Clin North Am; 2016 Jun; 39(2):199-216. PubMed ID: 27216900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
    Jaeger S; Weißhaupt S; Flammer E; Steinert T
    Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.